1
Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple Myeloma
Condition(s): Relapse; Refractory Multiple Myeloma Last Updated: August 3, 2009Completed
5154 Clinical Trials for: Refractory, Page 1 of 258
Hide Studies Not Seeking New Volunteers
2
Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia
Condition(s): Blastic Phase Chronic Myelogenous Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Refractory Anemia With Excess Blasts; Relapsing Chronic Myelogenous Leukemia; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia Last Updated: April 1, 2013Completed
3
Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib in Subjects With Relapsed/Refractory Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: March 12, 2013Recruiting
4
Methylprednisolone Pulse Macrolide Therapy for Refractory Mycoplasma Pneumoniae Pneumonia in Children
Condition(s): Refractory Mycoplasma Pneumoniae Pneumonia Last Updated: October 7, 2010Terminated
5
Multi-center Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Condition(s): Chronic Lymphocytic Leukemia; CLL Last Updated: September 9, 2010Recruiting
6
Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
Condition(s): Relapsed and Bortezomib Refractory Multiple Myeloma; Refractory Multiple Myeloma; Relapsed Multiple Myeloma Last Updated: November 14, 2012Active, not recruiting
7
Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies
Condition(s): Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Stage III Chronic Lymphocytic Leukemia; Testicular Lymphoma; Waldenström Macroglobulinemia Last Updated: February 6, 2013Recruiting
8
A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia
Condition(s): Chronic Lymphocytic Leukemia Last Updated: May 2, 2011Active, not recruiting
9
Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: May 2, 2013Active, not recruiting
10
Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's Lymphoma
Condition(s): Prostate Cancer; Non-Hodgkins Lymphoma Last Updated: December 1, 2011Terminated
11
Study to Compare Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone Versus High-dose Dexamethasone in Subjects With Refractory or Relapsed and Refractory Multiple Myeloma
Condition(s): Multiple Myeloma Last Updated: February 20, 2013Active, not recruiting
12
Vorinostat and Pegylated Liposomal Doxorubicin in Relapsed or Refractory Lymphomas
Condition(s): Relapsed Lymphomas; Refractory Lymphomas Last Updated: June 5, 2009Recruiting
13
PK Trial of Sorafenib & Erlotinib in Patients With Refractory Solid Tumors
Condition(s): Refractory Solid Tumors Last Updated: August 28, 2012Active, not recruiting
14
Study of Cordycepin Plus Pentostatin in Patients With Refractory TdT-Positive Leukemia
Condition(s): Refractory TdT-Positive Leukemia Last Updated: January 8, 2009Recruiting
15
Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias
Condition(s): Anemia, Aplastic; Amegakaryocytic Thrombocytopenia; Diamond-Blackfan Anemia; Kostmann Syndrome Last Updated: May 1, 2012Completed
16
A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis
Condition(s): Pelvic Pain Associated With Refractory Endometriosis Last Updated: July 20, 2011Terminated
17
Efficacy and Safety of Panobinostat (LBH5789) in Patients With Refractory de Novo or Secondary Acute Myelogenous Leukemia (AML)
Condition(s): Refractory Leukemia; Acute Myelogenous Leukemia Last Updated: April 18, 2013Completed
18
Evaluation of Efficacy and Safety of Susanna Implant in Patients With Refractory Glaucoma.
Condition(s): Glaucoma Last Updated: May 9, 2011Not yet recruiting
19
TC-5214 as Augmentation Therapy in Patients With Refractory Hypertension
Condition(s): Refractory Hypertension Last Updated: July 13, 2012Terminated
20
Clinical Study of Plitidepsin (Aplidin®) in Combination With Cytarabine in Patients With Relapsed/Refractory Leukemia
Condition(s): Relapsed/Refractory Leukemia Last Updated: November 23, 2009Terminated
